Stauffer's Syndrome in Pancreatic Cancer: First Case Report
- PMID: 28611937
- PMCID: PMC5464792
- DOI: 10.7759/cureus.1230
Stauffer's Syndrome in Pancreatic Cancer: First Case Report
Abstract
Stauffer's syndrome is a rare paraneoplastic syndrome classically associated with renal cell carcinoma. It presents as abnormal hepatic panel in the absence of hepatic disease, which improves with treatment of the cancer and worsens with recurrence. Here, we describe a case of hepatic panel abnormalities in a patient with pancreatic cancer with no evidence of metastatic disease to the liver, primary hepatobiliary etiology, or clear offending medications. We believe this to be the first reported case of Stauffer's syndrome in patients with pancreatic cancer.
Keywords: abnormal liver functions; hypercoagulability; metastases; pancreatic cancer; paraneoplastic syndrome; stauffer's syndrome.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- The spectrum of cholestatic hepatic disease. Stauffer MH, Sauer WG, Dearing WH, et al. JAMA. 1965;191:829–837. - PubMed
-
- Is Stauffer's syndrome an early indicator of RCC recurrence? Girotra M, Abraham RR, Pahwa M, et al. ANZ J Surg. 2010;80:949–950. - PubMed
-
- Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma. Karakolios A, Kasapis C, Kallinikidis T, et al. http://www.cghjournal.org/article/S1542-3565(03)00227-1/abstract. Clin Gastroenterol Hepatol. 2003;1:480–483. - PubMed
-
- Stauffer syndrome in transitional cell carcinoma of the bladder. Moreno-palacios J, Wingartz-plata H, Pardo-belasteguigoitia P, et al. https://www.ncbi.nlm.nih.gov/pubmed/?term=Stauffer+syndrome+in+transitio.... Arch Esp Urol. 2011;64:911–913. - PubMed
-
- Saif MW, Tejani MA. Clin Adv Hematol Oncol. Vol. 5. Sep: 2007. Safety of capecitabine use in patients with liver dysfunction; pp. 730–732. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources